Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Nutt

Showing results (111-120 of 389) with videos related to

Pageof 39
Sort By:
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|January 24, 2007
Dopamine and social anxiety disorderHayley M Robinson, Sean D Hood, Caroline J Bell, et al.
Acta Psychiatrica Scandinavica|October 30, 2020
Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studiesKristoffer A A Andersen, Robin Carhart-Harris, David J Nutt, et al.
Brain Research|December 16, 2014
The modulatory action of harmane on serotonergic neurotransmission in rat brainHaya Abu Ghazaleh, Maggie D Lalies, David J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|August 9, 2015
Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 1, a pharmacokinetic/pharmacodynamic comparison with paroxetine in healthy menSue Wilson, Astrid-Maria Højer, Jeppe Buchberg, et al.
Neuroscience Letters|January 28, 2015
Harmane: an atypical neurotransmitter?Haya Abu Ghazaleh, Maggie D Lalies, David J Nutt, et al.
Depression and Anxiety|March 23, 2005
Behavioral and cardiovascular effects of 7.5% CO2 in human volunteersJayne E Bailey, Spilios V Argyropoulos, Adrian H Kendrick, et al.
Journal of Psychopharmacology (Oxford, England)|October 14, 2011
Validating the inhalation of 7.5% CO(2) in healthy volunteers as a human experimental medicine: a model of generalized anxiety disorder (GAD)Jayne E Bailey, Gerard R Dawson, Colin T Dourish, et al.
BMJ (Clinical Research Ed.)|April 17, 2004
Treatment of anxiety and depressive disorders in patients with cardiovascular diseaseSimon J C Davies, Peter R Jackson, John Potokar, et al.
Nature Reviews. Neuroscience|April 16, 2015
The dopamine theory of addiction: 40 years of highs and lowsDavid J Nutt, Anne Lingford-Hughes, David Erritzoe, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 27, 2004
Orexin-A infusion in the locus ceruleus triggers norepinephrine (NE) release and NE-induced long-term potentiation in the dentate gyrusSusan G Walling, David J Nutt, Margaret D Lalies, et al.
Pageof 39

Showing results (111-120 of 389) with videos related to

Sort By:
Pageof 39
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|January 24, 2007
Dopamine and social anxiety disorderHayley M Robinson, Sean D Hood, Caroline J Bell, et al.
Acta Psychiatrica Scandinavica|October 30, 2020
Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studiesKristoffer A A Andersen, Robin Carhart-Harris, David J Nutt, et al.
Brain Research|December 16, 2014
The modulatory action of harmane on serotonergic neurotransmission in rat brainHaya Abu Ghazaleh, Maggie D Lalies, David J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|August 9, 2015
Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 1, a pharmacokinetic/pharmacodynamic comparison with paroxetine in healthy menSue Wilson, Astrid-Maria Højer, Jeppe Buchberg, et al.
Neuroscience Letters|January 28, 2015
Harmane: an atypical neurotransmitter?Haya Abu Ghazaleh, Maggie D Lalies, David J Nutt, et al.
Depression and Anxiety|March 23, 2005
Behavioral and cardiovascular effects of 7.5% CO2 in human volunteersJayne E Bailey, Spilios V Argyropoulos, Adrian H Kendrick, et al.
Journal of Psychopharmacology (Oxford, England)|October 14, 2011
Validating the inhalation of 7.5% CO(2) in healthy volunteers as a human experimental medicine: a model of generalized anxiety disorder (GAD)Jayne E Bailey, Gerard R Dawson, Colin T Dourish, et al.
BMJ (Clinical Research Ed.)|April 17, 2004
Treatment of anxiety and depressive disorders in patients with cardiovascular diseaseSimon J C Davies, Peter R Jackson, John Potokar, et al.
Nature Reviews. Neuroscience|April 16, 2015
The dopamine theory of addiction: 40 years of highs and lowsDavid J Nutt, Anne Lingford-Hughes, David Erritzoe, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 27, 2004
Orexin-A infusion in the locus ceruleus triggers norepinephrine (NE) release and NE-induced long-term potentiation in the dentate gyrusSusan G Walling, David J Nutt, Margaret D Lalies, et al.
Pageof 39